Several antiphospholipid antibody (aPL) profiles (“triple” and lupus anticoagulant [LA]
positivity) are associated with a higher risk for clinical manifestations of antiphospholipid …

Introduction: Antiphospholipid syndrome (APS) is an acquired autoimmune thrombophilia
associated with the presence of persistent antiphospholipid antibodies (aPL). Owing to …

Abstract Background The APS ACTION International Clinical Database and Repository
includes a secure web-based data capture system storing patient information including …

Summary Immunoglobulin (Ig) G/IgM autoantibodies to phosphatidylserine/prothrombin
(aPS/PT) were evaluated individually and in combination with criteria anti-phospholipid …

The place of non-criteria antiphospholipid antibodies (aPLs) in the diagnosis of
antiphospholipid syndrome (APS) is still debatable. The aim of this research was to evaluate …

The measurement of antiphospholipid antibodies (aPL) has been an important aspect of
antiphospholipid syndrome (APS) characterization since the disease was first described in …

Abstract Purpose of Review APS ACTION is an international research network created to
design and conduct large-scale, multicenter research in persistently antiphospholipid …

The laboratory criteria (lupus anticoagulants (LA), and/or anti-cardiolipin (aCL) antibodies
and/or anti-β2-glycoprotein I antibodies (aβ2GPI)) that define patients with antiphospholipid …

Detection of anti-phospholipid (aPL) antibodies for state-of-the art diagnosis of
antiphospholipid syndrome (APS) still remains a laboratory challenge due to the great …

Background: Antiphospholipid antibodies (aPLs) are antibodies directed against cell
membrane components and can be associated with clinical features or be asymptomatic …